alexa

GET THE APP
Acute myelogenous leukemia | Ireland| PDF | PPT| Case Reports | Symptoms | Treatment

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Acute Myelogenous Leukemia

  • Acute myelogenous leukemia

    A life-threatening disorder that predominantly occurs in older adults. Many subtypes exist, of which acute promyelocytic leukaemia merits specific management. Characteristically, abnormal blasts are present in the peripheral blood and normal haematopoiesis is reduced. Definitive diagnosis requires bone marrow biopsy. Presence of blast cells in >20% of the bone marrow cells confirms the diagnosis. Cytogenetic abnormalities are prognostically important and affect patient management.

  • Acute myelogenous leukemia

    Mortality Between 1950 and 1970 there was a rapid increase in leukaemia mortality, greater in males than females, (Figure 9). Some of this increase may have been due to better diagnosis.Patients with AML typically present with a normocytic, normochromic anemia that can vary in severity. This anemia worsens with induction chemotherapy and is managed primarily with blood transfusions. There is no role for the use of erythropoietic stimulating agents during induction therapy of AML.

  • Acute myelogenous leukemia

    Once the diagnosis of acute myeloid leukemia (AML) is established, induction chemotherapy is given with the goal of rapidly restoring normal bone marrow function. Among patients with AML, treatment regimens and outcomes may differ between younger and older adults. Although there is no clear dividing line between younger and older adults when dealing with AML, in most studies, "older adults" has been defined as over age 55 to 60 years. The initial treatment of younger adults with de novo AML will be reviewed here. The following exceptions, which require modification of standard treatment regimens, are discussed separately

     

Speaker PPTs

High Impact List of Articles

Conference Proceedings

International Conferences 2021-22
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Conferences by Country

USA Australia UAE Italy Germany UK Japan Brazil South Korea Netherlands
Spain Canada China France India Malaysia Singapore South Africa New Zealand Philippines
Poland Austria Turkey Finland Ukraine Denmark Mexico Norway Romania

Medical & Clinical Conferences

Microbiology Diabetes & Endocrinology Nursing Healthcare Management Neuroscience Immunology Gastroenterology Genetics & Molecular Biology Pathology Alternative Healthcare Pediatrics Ophthalmology
Oncology & Cancer Cardiology Dentistry Physical Therapy Rehabilitation Psychiatry Infectious Diseases Medical Ethics & Health Policies Palliativecare Reproductive Medicine & Women Healthcare Surgery Radiology

Conferences By Subject

Pharmaceutical Sciences Pharma Marketing & Industry Agri, Food & Aqua Nutrition Physics & Materials Science Environmental Science EEE & Engineering Veterinary Chemical Engineering Business Management Massmedia Geology & Earth science
Top